Instrument Inactif

Autres langues ISIS Pharmaceuticals, Inc. Nasdaq

Actions

US4643301090

Recherche biotechnologique et médicale

Autres langues

20/08	Ionis Pharmaceuticals Presents New Data In The Management Of Severe Hypertriglyceridemia At The European Society Of Cardiology Congress 2026
20/08	Ionis to present new data strengthening leadership in the management of severe hypertriglyceridemia (sHTG) at the European Society of Cardiology Congress 2026
31/07	Ionis Pharmaceuticals Insider Bought Shares Worth $1,058,700, According to a Recent SEC Filing
29/07	Ionis Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
29/07	Ionis Pharmaceuticals, Inc. Announces Retirement of Frank Bennett from Executive Vice President and Chief Scientific Officer Roles, Effective February 2027
29/07	Ionis Pharmaceuticals, Inc. Provides Earnings Guidance for the Full Year of 2026
29/07	Earnings Flash (IONS) Ionis Pharmaceuticals, Inc. Reports Q2 Revenue $268.0M, vs. FactSet Est of $189.1M
29/07	Earnings Flash (IONS) Ionis Pharmaceuticals Posts Q2 Loss $0.69 a Share, vs. FactSet Est of $1.08 Loss
29/07	Ionis Pharmaceuticals: Q2 Earnings Snapshot
29/07	Ionis announces Dr. Frank Bennett, chief scientific officer, to retire
29/07	Ionis reports second quarter 2026 financial results and highlights progress on key programs
15/07	Ionis to hold second quarter 2026 financial results webcast
14/07	Ionis Partner Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease
13/07	Ionis Pharmaceuticals, Inc. Doses First Participant in Phase 1-2 ASCEND Study of ION337 in Dravet Syndrome
13/07	Ionis Doses First Participant in Phase 1-2 Trial of Dravet Syndrome Therapy
13/07	Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
10/07	Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says
10/07	Ionis Pharmaceuticals Reaffirms Fiscal 2026 Financial Guidance
10/07	Analyst recommendations: Cubesmart, Fox Corporation, AMD, Crowdstrike, Micron…
10/07	Ionis Pharmaceuticals Insider Sold Shares Worth $1,744,623, According to a Recent SEC Filing
09/07	Health Care Down on Rotation Out of Defensive Sectors - Health Care Roundup
09/07	Top Midday Decliners
09/07	FTSE 100 held back by AstraZeneca trial setback
09/07	European Stocks Head Mostly Higher in Thursday Trading; Nokia, NestAI Team Up to Build Defense Products
09/07	Top Midday Stories: Tensions Rise as US, Iran Trade Attacks; Micron to Invest $3 Billion in US Semiconductor Supply Chain